Portal Biotechnologies, Inc., a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital. Portal is implementing a simplified approach to intracellular delivery, focused on accelerating advances in RNA,…
Scholar Rock said Monday it raised $36 million in a Series B financing round led by Fidelity Management and Research Company. New investor Cormorant Asset Management also participated as well as existing investors Polaris Partners, Timothy Springer, ARCH Venture Partners,…
Navitor Pharmaceuticals, Inc., a Cambridge, MA-based biopharmaceutical company developing novel medicines targeting the activation of mTORC1*, completed a $33m Series B financing. he round was led by new investor Brace Pharma Capital, LLC, a strategic investment company formed by EMS…